IS6448A - Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni - Google Patents

Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni

Info

Publication number
IS6448A
IS6448A IS6448A IS6448A IS6448A IS 6448 A IS6448 A IS 6448A IS 6448 A IS6448 A IS 6448A IS 6448 A IS6448 A IS 6448A IS 6448 A IS6448 A IS 6448A
Authority
IS
Iceland
Prior art keywords
amonoquinazole
bacterial properties
bacterial
properties
Prior art date
Application number
IS6448A
Other languages
English (en)
Inventor
Bird Paul
Peter Sanchez Joseph
Andrew Stier Michael
Yip Judy
Daniel Showalter Howard
Lee Ellisworth Edmund
Phong Tran Tuan
Quoc Nguyen Dai
Singh Rajeshwar
Morgan Watson Brian
Original Assignee
Warner-Lambert Company, , Delaware Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company, , Delaware Corporation filed Critical Warner-Lambert Company, , Delaware Corporation
Publication of IS6448A publication Critical patent/IS6448A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
IS6448A 2000-01-24 2002-06-27 Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni IS6448A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18
PCT/US2000/033656 WO2001053273A1 (en) 2000-01-24 2000-12-12 3-aminoquinazolin-2,4-dione antibacterial agents

Publications (1)

Publication Number Publication Date
IS6448A true IS6448A (is) 2002-06-27

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6448A IS6448A (is) 2000-01-24 2002-06-27 Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni

Country Status (38)

Country Link
US (2) US7094780B1 (is)
EP (1) EP1255739B1 (is)
JP (1) JP4811978B2 (is)
KR (1) KR20020067701A (is)
CN (1) CN1425008A (is)
AP (1) AP2002002603A0 (is)
AR (1) AR030186A1 (is)
AT (1) ATE398110T1 (is)
AU (1) AU783078B2 (is)
BG (1) BG107023A (is)
BR (1) BR0017010A (is)
CA (1) CA2393802C (is)
CO (1) CO5320600A1 (is)
CR (1) CR6709A (is)
DE (1) DE60039194D1 (is)
EA (1) EA005585B1 (is)
EE (1) EE200200412A (is)
ES (1) ES2304992T3 (is)
GE (1) GEP20053429B (is)
HK (1) HK1054237A1 (is)
HN (1) HN2001000009A (is)
HR (1) HRP20020696A2 (is)
HU (1) HUP0204101A3 (is)
IL (1) IL150393A0 (is)
IS (1) IS6448A (is)
MA (1) MA26866A1 (is)
MX (1) MXPA02005989A (is)
NO (1) NO20023516D0 (is)
OA (1) OA12316A (is)
PA (1) PA8510101A1 (is)
PE (1) PE20011060A1 (is)
PL (1) PL356837A1 (is)
SK (1) SK10572002A3 (is)
SV (1) SV2001000288A (is)
TN (1) TNSN01011A1 (is)
UY (1) UY26551A1 (is)
WO (1) WO2001053273A1 (is)
YU (1) YU55902A (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1264837C (zh) 1997-09-15 2006-07-19 普罗克特和甘保尔公司 喹诺酮抗微生物剂、其组合物和应用
DE60208541D1 (de) 2001-05-30 2006-03-30 Warner Lambert Co Antibakterielle mittel
WO2002102793A2 (en) * 2001-06-19 2002-12-27 Warner-Lambert Company Llc Quinazolinediones as antibacterial agents
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
CA2538420A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
JP2007511597A (ja) * 2003-11-18 2007-05-10 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌アミノキナゾリヂンヂオン誘導体
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
EP1844045B1 (en) * 2005-01-26 2009-11-04 F.Hoffmann-La Roche Ag Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
KR20110082635A (ko) 2006-03-28 2011-07-19 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
SI2001862T1 (sl) 2006-03-28 2011-10-28 Warner Chilcott Co Llc Soli malatov in polimorfi (3S, 5S)-7-(3-amino-5-metil-piperidinil)-1-ciklopropil-1,4-dihidro-8-metoksi- 4-okso-3-kinolinkarboksline kisline
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
NZ586552A (en) * 2008-01-30 2012-06-29 Shin Poong Pharmaceutical Co Ltd Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
CN103562208B (zh) 2011-03-15 2016-08-31 默沙东公司 三环促旋酶抑制剂
JP6075736B2 (ja) * 2011-12-21 2017-02-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
ES2984771T3 (es) 2012-06-13 2024-10-31 Incyte Holdings Corp Compuestos tricíclicos sustituidos como inhibidores de FGFR
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US10865216B2 (en) 2012-09-12 2020-12-15 Merck Sharp & Dohme Corp. Tricyclic Gyrase inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
ES2657451T3 (es) 2013-04-19 2018-03-05 Incyte Holdings Corporation Heterocíclicos bicíclicos como inhibidores del FGFR
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
CN107438607B (zh) 2015-02-20 2021-02-05 因赛特公司 作为fgfr抑制剂的双环杂环
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
FI3788047T3 (fi) 2018-05-04 2024-11-02 Incyte Corp Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi
JP7568512B2 (ja) 2018-05-04 2024-10-16 インサイト・コーポレイション Fgfr阻害剤の塩
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021076602A1 (en) 2019-10-14 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
AU2020395185A1 (en) 2019-12-04 2022-06-02 Incyte Corporation Derivatives of an FGFR inhibitor
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
TW202304459A (zh) 2021-04-12 2023-02-01 美商英塞特公司 包含fgfr抑制劑及nectin-4靶向劑之組合療法
TW202313611A (zh) 2021-06-09 2023-04-01 美商英塞特公司 作為fgfr抑制劑之三環雜環
EP4352060A1 (en) 2021-06-09 2024-04-17 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (is) * 1959-11-05
FR1203542A (fr) * 1958-02-25 1960-01-19 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
EP0035619B1 (fr) * 1980-03-10 1984-07-25 BERRI-BALZAC Société dite: Dérivés d'amino-3 (1H,3H) quinazolinedione-2,4
GB2097784A (en) * 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
WO1994014809A1 (de) 1992-12-23 1994-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellierte uracilderivate
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
AU9503998A (en) 1997-10-28 1999-05-17 Warner-Lambert Company Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
WO1999061444A2 (en) * 1998-05-26 1999-12-02 Warner-Lambert Company Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
CN1132819C (zh) * 1998-12-11 2003-12-31 霍夫曼-拉罗奇有限公司 作为TNF-α抑制剂的环状肼衍生物

Also Published As

Publication number Publication date
CR6709A (es) 2003-11-25
KR20020067701A (ko) 2002-08-23
SV2001000288A (es) 2001-11-30
NO20023516L (no) 2002-07-23
MXPA02005989A (es) 2002-10-23
JP2003520277A (ja) 2003-07-02
DE60039194D1 (de) 2008-07-24
BR0017010A (pt) 2002-11-05
WO2001053273A1 (en) 2001-07-26
HUP0204101A2 (hu) 2003-04-28
UY26551A1 (es) 2001-04-30
HRP20020696A2 (en) 2003-12-31
HUP0204101A3 (en) 2004-05-28
CA2393802C (en) 2011-04-19
MA26866A1 (fr) 2004-12-20
HK1054237A1 (zh) 2003-11-21
PE20011060A1 (es) 2001-10-12
EA200200661A1 (ru) 2003-02-27
US7582627B2 (en) 2009-09-01
CA2393802A1 (en) 2001-07-26
AR030186A1 (es) 2003-08-13
HN2001000009A (es) 2001-06-13
EP1255739B1 (en) 2008-06-11
PL356837A1 (en) 2004-07-12
JP4811978B2 (ja) 2011-11-09
BG107023A (en) 2003-04-30
CO5320600A1 (es) 2003-09-30
ES2304992T3 (es) 2008-11-01
EE200200412A (et) 2003-10-15
EA005585B1 (ru) 2005-04-28
ATE398110T1 (de) 2008-07-15
NO20023516D0 (no) 2002-07-23
AP2002002603A0 (en) 2002-09-30
YU55902A (sh) 2006-01-16
GEP20053429B (en) 2005-01-25
PA8510101A1 (es) 2003-06-30
US20060183762A1 (en) 2006-08-17
US7094780B1 (en) 2006-08-22
CN1425008A (zh) 2003-06-18
IL150393A0 (en) 2002-12-01
AU2089901A (en) 2001-07-31
SK10572002A3 (sk) 2003-10-07
AU783078B2 (en) 2005-09-22
EP1255739A1 (en) 2002-11-13
TNSN01011A1 (en) 2005-11-10
OA12316A (en) 2006-05-15
US20060287308A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
IS6448A (is) Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni
EP1197749A4 (en) BIOSENSOR
EP1223425A4 (en) BIOSENSOR
EP1347292A4 (en) BIOSENSOR
EP1314978A4 (en) BIOSENSOR
EP1296141A4 (en) BIOZENSOR
BR0113116B1 (pt) banheira.
DE60123142D1 (de) Biosensor
MA25850A1 (fr) Conjugues de pro-parfums photolabiles.
EP1202059A4 (en) BIOSENSOR
NL1017075A1 (nl) Preparaat.
MX242679B (es) Antranilamidas insecticidas.
MXPA03001148A (es) Antibioticos macrolidos.
FI20000004A0 (fi) Flavonoidilääke...
BR0200521B1 (pt) artigo higiênico.
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
CH695519A5 (de) Sperrstromthyristor.
EP1343870A4 (en) BACTERIAL EXPRESSION
DE10191181D2 (de) Nachweis von Diarrhogenen E.Coli-Keimen
NL1014850A1 (nl) Grafkist.
ES1046656Y (es) Microplanta de transferencia de residuos solidos urbanos.
ITRM20000040V0 (it) Easy playnet.
DE10104914B4 (de) Lager
DK1246934T3 (da) Mikrobielle vækstvariationer
ES1045979Y (es) Expendedor de tickes de turno.